Asa SL, Mete O, Perry A, Osamura RY (2022) Overview of the 2022 WHO Classification of Pituitary Tumors. Endocr Pathol 33:6–26. https://doi.org/10.1007/s12022-022-09703-7

Article  CAS  PubMed  Google Scholar 

Gold EB (1981) Epidemiology of pituitary adenomas. Epidemiol Rev 3:163–183. https://doi.org/10.1093/oxfordjournals.epirev.a036232

Article  CAS  PubMed  Google Scholar 

Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, McCutcheon IE (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101:613–619. https://doi.org/10.1002/cncr.20412

Article  PubMed  Google Scholar 

Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 91:4769–4775. https://doi.org/10.1210/jc.2006-1668

Article  CAS  PubMed  Google Scholar 

Fontana E, Gaillard R (2009) [Epidemiology of pituitary adenoma: results of the first Swiss study]. Rev Med Suisse 5:2172–2174

CAS  PubMed  Google Scholar 

Fernandez A, Karavitaki N, Wass JAH (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf) 72:377–382. https://doi.org/10.1111/j.1365-2265.2009.03667.x

Article  Google Scholar 

Daly AF, Beckers A (2017) Chapter 21 - Genetics of Pituitary Tumor Syndromes. In: Melmed SBT-TP (Fourth E (ed). Academic Press, pp 619–630

Daly AF, Tichomirowa MA, Beckers A (2009) The epidemiology and genetics of pituitary adenomas. Best Pract Res Clin Endocrinol Metab 23:543–554. https://doi.org/10.1016/j.beem.2009.05.008

Article  CAS  PubMed  Google Scholar 

Daly AF, Jaffrain-Rea M-L, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G, Borson-Chazot C, Estour B, Ciccarelli E, Brue T, Ferolla P, Emy P, Colao A, De Menis E, Lecomte P, Penfornis F, Delemer B, Bertherat J, Wémeau JL, De Herder W, Archambeaud F, Stevenaert A, Calender A, Murat A, Cavagnini F, Beckers A (2006) Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab 91:3316–3323. https://doi.org/10.1210/jc.2005-2671

Article  CAS  PubMed  Google Scholar 

European Chromosome 16 Tuberous Sclerosis Consortium (1993) Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75:1305–1315. https://doi.org/10.1016/0092-8674(93)90618-z

Article  Google Scholar 

Kandt RS, Haines JL, Smith M, Northrup H, Gardner RJ, Short MP, Dumars K, Roach ES, Steingold S, Wall S (1992) Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 2:37–41. https://doi.org/10.1038/ng0992-37

Article  CAS  PubMed  Google Scholar 

Dénes J, Swords F, Rattenberry E, Stals K, Owens M, Cranston T, Xekouki P, Moran L, Kumar A, Wassif C, Fersht N, Baldeweg SE, Morris D, Lightman S, Agha A, Rees A, Grieve J, Powell M, Boguszewski CL, Dutta P, Thakker RV, Srirangalingam U, Thompson CJ, Druce M, Higham C, Davis J, Eeles R, Stevenson M, O’Sullivan B, Taniere P, Skordilis K, Gabrovska P, Barlier A, Webb SM, Aulinas A, Drake WM, Bevan JS, Preda C, Dalantaeva N, Ribeiro-Oliveira AJ, Garcia IT, Yordanova G, Iotova V, Evanson J, Grossman AB, Trouillas J, Ellard S, Stratakis CA, Maher ER, Roncaroli F, Korbonits M (2015) Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort. J Clin Endocrinol Metab 100:E531-541. https://doi.org/10.1210/jc.2014-3399

Article  CAS  PubMed  Google Scholar 

Xekouki P, Stratakis CA (2012) Succinate dehydrogenase (SDHx) mutations in pituitary tumors: could this be a new role for mitochondrial complex II and/or Krebs cycle defects? Endocr Relat Cancer 19:C33-40. https://doi.org/10.1530/ERC-12-0118

Article  CAS  PubMed  PubMed Central  Google Scholar 

Benn DE, Robinson BG, Clifton-Bligh RJ (2015) 15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1-5. Endocr Relat Cancer 22:T91-103. https://doi.org/10.1530/ERC-15-0268

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xekouki P, Brennand A, Whitelaw B, Pacak K, Stratakis CA (2019) The 3PAs: An Update on the Association of Pheochromocytomas, Paragangliomas, and Pituitary Tumors. Horm Metab Res Horm Stoffwechselforschung Horm Metab 51:419–436. https://doi.org/10.1055/a-0661-0341

Article  CAS  Google Scholar 

Vasilev V, Daly AF, Zacharieva S, Beckers A (2020) Clinical and Molecular Update on Genetic Causes of Pituitary Adenomas. Horm Metab Res Horm Stoffwechselforschung Horm Metab 52:553–561. https://doi.org/10.1055/a-1143-5930

Article  CAS  Google Scholar 

Srirangam Nadhamuni V, Korbonits M (2020) Novel Insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms. Endocr Rev 41:821–846. https://doi.org/10.1210/endrev/bnaa006

Article  PubMed Central  Google Scholar 

Manoharan J, Bollmann C, Kann PH, Di Fazio P, Bartsch DK, Albers MB (2020) Gender Differences in Multiple Endocrine Neoplasia Type 1: Implications for Screening? Visc Med 36:3–9. https://doi.org/10.1159/000505498

Article  PubMed  PubMed Central  Google Scholar 

Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TML, Salmela PI, Paschke R, Gündogdu S, De Menis E, Mäkinen MJ, Launonen V, Karhu A, Aaltonen LA (2006) Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312:1228–1230. https://doi.org/10.1126/science.1126100

Article  CAS  PubMed  Google Scholar 

Daly AF, Vanbellinghen J-F, Khoo SK, Jaffrain-Rea M-L, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez-Roqueplo A-P, Tamburrano G, Raverot G, Barlier A, De Herder W, Penfornis A, Ciccarelli E, Estour B, Lecomte P, Gatta B, Chabre O, Sabaté MI, Bertagna X, Garcia Basavilbaso N, Stalldecker G, Colao A, Ferolla P, Wémeau J-L, Caron P, Sadoul J-L, Oneto A, Archambeaud F, Calender A, Sinilnikova O, Montañana CF, Cavagnini F, Hana V, Solano A, Delettieres D, Luccio-Camelo DC, Basso A, Rohmer V, Brue T, Bours V, Teh BT, Beckers A (2007) Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 92:1891–1896. https://doi.org/10.1210/jc.2006-2513

Article  CAS  PubMed  Google Scholar 

Vasilev V, Daly AF, Trivellin G, Stratakis CA, Zacharieva S, Beckers A (2020) HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA). Endocr Relat Cancer 27:T77–T86. https://doi.org/10.1530/ERC-20-0015

Article  CAS  PubMed  Google Scholar 

Hernández-Ramírez LC, Gabrovska P, Dénes J, Stals K, Trivellin G, Tilley D, Ferrau F, Evanson J, Ellard S, Grossman AB, Roncaroli F, Gadelha MR, Korbonits M (2015) Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers. J Clin Endocrinol Metab 100:E1242-54. https://doi.org/10.1210/jc.2015-1869

Article  PubMed  PubMed Central  Google Scholar 

Schöfl C, Honegger J, Droste M, Grussendorf M, Finke R, Plöckinger U, Berg C, Willenberg HS, Lammert A, Klingmüller D, Jaursch-Hancke C, Tönjes A, Schneidewind S, Flitsch J, Bullmann C, Dimopoulou C, Stalla G, Mayr B, Hoeppner W, Schopohl J (2014) Frequency of AIP gene mutations in young patients with acromegaly: a registry-based study. J Clin Endocrinol Metab 99:E2789-93. https://doi.org/10.1210/jc.2014-2094

Article  CAS  PubMed  Google Scholar 

Korbonits M, Storr H, Kumar A V (2012) Familial pituitary adenomas - who should be tested for AIP mutations? Clin Endocrinol (Oxf) 77:351–356. https://doi.org/10.1111/j.1365-2265.2012.04445.x

Article  CAS  Google Scholar 

Lu R, Pu C, Pekmeczi M, Perry A (2022) Immature PIT1-Lineage Pituitary Neuroendocrine Tumor: a 17-Year-Old Male with Pathogenic AIP Mutation. Endocr Pathol 33:414–416. https://doi.org/10.1007/s12022-022-09723-3

Article  CAS  PubMed  Google Scholar 

Gonzalez C, Rosas-Hernandez H, Jurado-Manzano B, Ramirez-Lee MA, Salazar-Garcia S, Martinez-Cuevas PP, Velarde-Salcedo AJ, Morales-Loredo H, Espinosa-Tanguma R, Ali SF, Rubio R (2015) The prolactin family hormones regulate vascular tone through NO and prostacyclin production in isolated rat aortic rings. Acta Pharmacol Sin 36:572–586. https://doi.org/10.1038/aps.2014.159

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tichomirowa MA, Barlier A, Daly AF, Jaffrain-Rea M-L, Ronchi C, Yaneva M, Urban JD, Petrossians P, Elenkova A, Tabarin A, Desailloud R, Maiter D, Schürmeyer T, Cozzi R, Theodoropoulou M, Sievers C, Bernabeu I, Naves LA, Chabre O, Montañana CF, Hana V, Halaby G, Delemer B, Aizpún JIL, Sonnet E, Longás AF, Hagelstein M-T, Caron P, Stalla GK, Bours V, Zacharieva S, Spada A, Brue T, Beckers A (2011) High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas. Eur J Endocrinol 165:509–515. https://doi.org/10.1530/EJE-11-0304

Article  CAS  PubMed  Google Scholar 

Hernández-Ramírez LC, Martucci F, Morgan RML, Trivellin G, Tilley D, Ramos-Guajardo N, Iacovazzo D, D’Acquisto F, Prodromou C, Korbonits M (2016) Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations. J Clin Endocrinol Metab 101:3144–3154. https://doi.org/10.1210/jc.2016-1307

Article  CAS  PubMed  PubMed Central  Google Scholar 

Igreja S, Chahal HS, King P, Bolger GB, Srirangalingam U, Guasti L, Chapple JP, Trivellin G, Gueorguiev M, Guegan K, Stals K, Khoo B, Kumar A V, Ellard S, Grossman AB, Korbonits M (2010) Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families. Hum Mutat 31:950–960. https://doi.org/10.1002/humu.21292

Article  CAS  PubMed  PubMed Central  Google Scholar 

Daly AF, Tichomirowa MA, Petrossians P, Heliövaara E, Jaffrain-Rea M-L, Barlier A, Naves LA, Ebeling T, Karhu A, Raappana A, Cazabat L, De Menis E, Montañana CF, Raverot G, Weil RJ, Sane T, Maiter D, Neggers S, Yaneva M, Tabarin A, Verrua E, Eloranta E, Murat A, Vierimaa O, Salmela PI, Emy P, Toledo RA, Sabaté MI, Villa C, Popelier M, Salvatori R, Jennings J, Longás AF, Labarta Aizpún JI, Georgitsi M, Paschke R, Ronchi C, Valimaki M, Saloranta C, De Herder W, Cozzi R, Guitelman M, Magri F, Lagonigro MS, Halaby G, Corman V, Hagelstein M-T, Vanbellinghen J-F, Barra GB, Gimenez-Roqueplo A-P, Cameron FJ, Borson-Chazot F, Holdaway I, Toledo SPA, Stalla GK, Spada A, Zacharieva S, Bertherat J, Brue T, Bours V, Chanson P, Aaltonen LA, Beckers A (2010) Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab 95:E373-83. https://doi.org/10.1210/jc.2009-2556

Article  PubMed  Google Scholar 

Preda V, Korbonits M, Cudlip S, Karavitaki N, Grossman AB (2014) Low rate of germline AIP mutations in patients with apparently sporadic pituitary adenomas before the age of 40: a single-centre adult cohort. Eur J Endocrinol 171:659–666. https://doi.org/10.1530/EJE-14-0426

Article  CAS  PubMed  Google Scholar